Stay updated on Subcutaneous Atezolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous Atezolizumab in NSCLC Clinical Trial page.

Latest updates to the Subcutaneous Atezolizumab in NSCLC Clinical Trial page
- Check4 days agoChange DetectedUpdated to v3.0.2 (replacing v3.0.1) and removed the 'Back to Top' element.SummaryDifference0.8%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.8%
- Check19 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, while several location-related terms have been removed.SummaryDifference9%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
- Check40 days agoChange DetectedThe page has undergone a revision change from v2.16.10 to v2.16.11, and a date has been updated from 2024-02-13 to 2025-08-06. Additionally, the term 'Recruiting' has been removed, and 'insufficient accrual' and 'Terminated' have been added.SummaryDifference1%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference4%
Stay in the know with updates to Subcutaneous Atezolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous Atezolizumab in NSCLC Clinical Trial page.